Age-Dependent Reference Values for hs-Troponin T and NT-proBNP and Determining Factors in a Cohort of Healthy Children (The LIFE Child Study)

Alexandra Kiess, Jessica Green, Anja Willenberg, Uta Ceglarek, Ingo Dähnert, Anne Jurkutat, Antje Körner, Andreas Hiemisch, Wieland Kiess, Mandy Vogel, Alexandra Kiess, Jessica Green, Anja Willenberg, Uta Ceglarek, Ingo Dähnert, Anne Jurkutat, Antje Körner, Andreas Hiemisch, Wieland Kiess, Mandy Vogel

Abstract

This study aimed to provide reliable pediatric reference values for N-terminal pro-brain natriuretic peptide (NT-proBNP) and high-sensitive Troponin T (hsTnT) obtained from a population of well children and investigate for associations with sex, pubertal status, body mass index (BMI), and serum lipid levels. We analyzed hsTnT and NT-proBNP values obtained from 4826 samples provided by 2522 children aged 0.25-18 years participating in a prospective longitudinal population-based cohort study, "LIFE child" in Leipzig, Germany (Poulain et al., Eur J Epidemiol 32:145-158, 2017). NT-proBNP values decreased throughout childhood from values over 400 ng/L at 3 months to 138 ng/L in females and 65 ng/L in males by 18 years of age. Values dropped rapidly with advancing pubertal stage. We found a strong association between lower NT-proBNP values and higher BMI or elevated serum lipids, the latter effect being more pronounced in males. For hsTnT levels, approximately half of the measurements were below the detection limit. However, 76% of those aged 3 months and 21% of those aged 6 months had values exceeding the adult cut-off limit. Females had slightly higher levels in the first 2 years of life but this was reversed during puberty. In males, there was an upward trend from pubertal stage 2 onward. We identified a positive association between hsTnT and BMI but a negative association with low-density lipoprotein (LDL) cholesterol and triglyceride levels in boys but not in girls. Based on a large number of healthy children, we have established reliable reference values for NT-proBNP and hsTnT for use in everyday clinical practice. We have also identified important associations between certain metabolic and cardiac markers.Clinical Trial Registration ClinicalTrial.gov (NCT02550236).

Keywords: Cardiac biomarkers; NT-ProBNP; Pediatric percentiles; Troponin T.

Conflict of interest statement

All authors declare that they have no conflict of interest or financial ties to disclose.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
New NT-proBNP percentiles in the pediatric population from the LIFE Child Study cohort (n = 2489). 5th, 50th (median), 75th, 95th, and 97.5th (cut-off) percentiles for females and males showing a significant age-dependent decline and generally higher values in females. NT-proBNP levels were determined with ECLIA, Cobas Roche (n = 4648)
Fig. 2
Fig. 2
Influence of pubertal stage on NT-proBNP levels in the LIFE Child Study cohort. Box-plots represent the 25th and 75th percentiles (boxes) and 50th percentile (mid line). NT-proBNP levels were higher in girls than in boys with an increasing effect in advancing puberty and dropped significantly in both genders again with an increasing effect in ongoing puberty until stage 4, from where only levels in males decreased further. NT-proBNP levels were determined with ECLIA, Cobas Roche (n = 2537)
Fig. 3
Fig. 3
New hs-Troponin T percentiles in the pediatric population from the LIFE Child Study cohort (n = 2489). 5th, 50th (median), 75th, 95th, and 97.5th (cut-off) percentiles for females and males showing a significant age-dependent decline in the first year of life and generally values below the adult cut-off, as well as a surprising rise in teenage boys. hs-Troponin T levels were determined with ECLIA, Cobas Roche (n = 4337)
Fig. 4
Fig. 4
Influence of pubertal stage on hs-Troponin levels in the LIFE Child Study cohort. Box-plots represent the 25th and 75th percentiles (boxes) and 50th percentile (mid line). Hs-Troponin levels were lower in females with an increasing effect during puberty and rose from pubertal stage 2 onward in males. Levels were determined with ECLIA, Cobas Roche (n = 2453, levels of children older than 6 years of age)
Fig. 5
Fig. 5
NT-proBNP and hs-Troponin T levels above the 90th percentile increase the probability of the alternate marker to be above the 90th percentile. Our study cohort showed no direct correlation between NT-proBNP and hs-Troponin T values, but an increasing probability of levels above the 90th percentile for NT-proBNP, respectively, hs-Troponin T, when the other marker was above the 97th versus the 90th percentile

References

    1. Poulain T, Baber R, Vogel M, Pietzner D, Kirsten T, Jurkutat A, et al. The LIFE Child Study: a population-based perinatal and pediatric cohort in Germany. Eur J Epidemiol. 2017;32:145–158. doi: 10.1007/s10654-016-0216-9.
    1. Valverde I, Singh Y, Sanchez-de-Toledo J, Theocharis P, Chikermane A, Di Filippo S, et al. Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe. Circulation. 2021;143:21–32. doi: 10.1161/CIRCULATIONAHA.120.050065.
    1. Nir A, Lindinger A, Rauh M, Bar-Oz B, Laer S, Schwachtgen L, et al. NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol. 2008;30:3–8. doi: 10.1007/s00246-008-9258-4.
    1. Albers S, Mir TS, Haddad M, Läer S. N-terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability. Clin Chem Lab Med. 2006;44:80–85. doi: 10.1515/CCLM.2006.016.
    1. Lam E, Higgins V, Zhang L, Chan MK, Bohn MK, Trajcevski K, et al. Normative values of high-sensitivity cardiac Troponin T and N-terminal pro-B-type natriuretic peptide in children and adolescents: a study from the CALIPER cohort. J Appl Lab Med. 2021;6:344–353. doi: 10.1093/jalm/jfaa090.
    1. Koerbin G, Abhayaratna WP, Potter JM, Apostoloska S, Telford RD, Hickman PE. NTproBNP concentrations in healthy children. Clin Biochem. 2012;45:1158–1160. doi: 10.1016/j.clinbiochem.2012.05.008.
    1. Suthahar N, Meems LMG, Groothof D, Bakker SJL, Gansevoort RT, van Veldhuisen DJ, et al. Relationship between body mass index, cardiovascular biomarkers and incident heart failure. Eur J Heart Fail. 2021;23:396–402. doi: 10.1002/ejhf.2102.
    1. Patel N, Gutiérrez OM, Arora G, Howard G, Howard VJ, Judd SE, et al. Race-based demographic, anthropometric and clinical correlates of N-terminal-pro B-type natriuretic peptide. Int J Cardiol. 2019;286:145–151. doi: 10.1016/j.ijcard.2019.02.034.
    1. Choi H-I, Lee MY, Oh BK, Lee SJ, Kang JG, Lee SH, et al. Effects of age, sex, and obesity on N-terminal pro B-type natriuretic peptide concentrations in the general population. Circ J. 2021;85:647–654. doi: 10.1253/circj.CJ-20-1104.
    1. Siervo M, Ruggiero D, Sorice R, Nutile T, Aversano M, Iafusco M, Vetrano F, Wells JC, Stephan BC, Ciullo M. Body mass index is directly associated with biomarkers of angiogenesis and inflammation in children and adolescents. Nutrition. 2012;28:262–266. doi: 10.1016/j.nut.2011.06.007.
    1. Battal F, Ermis B, Aktop Z, Can M, Demirel F. Early cardiac abnormalities and serum N-terminal pro B-type natriuretic peptide levels in obese children. JPEM. 2011;24:723–726. doi: 10.1515/JPEM.2011.285.
    1. Quante M, Hesse M, Döhnert M, Fuchs M, Hirsch C, Sergeyev E, et al. The LIFE Child Study: a life course approach to disease and health. BMC Public Health. 2012;12:1021. doi: 10.1186/1471-2458-12-1021.
    1. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44:291–303. doi: 10.1136/adc.44.235.291.
    1. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970;45:13–23. doi: 10.1136/adc.45.239.13.
    1. World Medical Association World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–2194. doi: 10.1001/jama.2013.281053.
    1. Dathan-Stumpf A, Vogel M, Hiemisch A, Thiery J, Burkhardt R, Kratzsch J, et al. Pediatric reference data of serum lipids and prevalence of dyslipidemia: results from a population-based cohort in Germany. Clin Biochem. 2016;49:740–749. doi: 10.1016/j.clinbiochem.2016.02.010.
    1. Borghi E, de Onis M, Garza C, Van den Broeck J, Frongillo EA, Grummer-Strawn L, et al. Construction of the World Health Organization child growth standards: selection of methods for attained growth curves. Stat Med. 2006;25:247–265. doi: 10.1002/sim.2227.
    1. Stasinopoulos MD, Rigby R, Heller G, Voudouris V, Bastiani F. Flexible regression and smoothing: using GAMLSS in R. 1. Boca Raton: Chapman and Hall/CRC; 2017.
    1. gamlss.cens-package: fitting an interval response variable using “gamlss.family” in gamlss.cens: fitting an interval response variable using ‘gamlss.family’ distributions (n.d.). . Accessed 30 April 2021
    1. Moss A, Kunze D, Wabitsch M. Evidence-based therapy guideline of the German Working Group on Obesity in Childhood and Adolescence. Bundesgesundh Gesundh Gesundh. 2011;54:584–590. doi: 10.1007/s00103-011-1269-2.
    1. R Core Team (2021) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. . Accessed 30 April 2021
    1. Soldin SJ, Soldin OP, Boyajian AJ, Taskier MS. Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals. Clin Chim Acta. 2006;366:304–308. doi: 10.1016/j.cca.2005.11.005.
    1. Koch A, Singer H. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart. 2003;89:875–878. doi: 10.1136/heart.89.8.875.
    1. Cantinotti M, Law Y, Vittorini S, Crocetti M, Marco M, Murzi B, et al. The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update. Heart Fail Rev. 2014;19:727–742. doi: 10.1007/s10741-014-9422-2.
    1. Fradley MG, Larson MG, Cheng S, McCabe E, Coglianese E, Shah RV, et al. Reference limits for N-terminal-pro-B-type natriuretic peptide in healthy individuals (from the Framingham Heart Study) Am J Cardiol. 2011;108:1341–1345. doi: 10.1016/j.amjcard.2011.06.057.
    1. Chang AY, Abdullah SM, Jain T, Stanek HG, Das SR, McGuire DK, et al. Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study. J Am Coll Cardiol. 2007;49:109–116. doi: 10.1016/j.jacc.2006.10.040.
    1. Saenger AK, Dalenberg DA, Bryant SC, Grebe SK, Jaffe AS. Pediatric brain natriuretic peptide concentrations vary with age and sex and appear to be modulated by testosterone. Clin Chem. 2009;55:1869–1875. doi: 10.1373/clinchem.2009.123778.
    1. Pervanidou P, Margeli A, Akalestos A, Sakka S, Kanaka-Gantenbein C, Papassotiriou I, Chrousos GP. Associations between circulating N-terminal pro-brain natriuretic peptide (NT-proBNP) and adiponectin concentrations depend on obesity level in female adolescents: gender dimorphic findings. Horm Metab Res. 2009;41:829–833. doi: 10.1055/s-0029-1233459.
    1. Pervanidou P, Akalestos A, Sakka S, Kanaka-Gantenbein C, Papassotiriou I, Chrousos GP. Gender dimorphic associations between N-terminal pro-brain natriuretic peptide, body mass index and blood pressure in children and adolescents. Horm Res Paediatr. 2010;73:341–348. doi: 10.1159/000308166.
    1. Karlén J, Karlsson M, Eliasson H, Bonamy A-KE, Halvorsen CP. Cardiac Troponin T in healthy full-term infants. Pediatr Cardiol. 2019;40:1645–1654. doi: 10.1007/s00246-019-02199-9.
    1. Caselli C, Cangemi G, Masotti S, Ragusa R, Gennai I, Del Ry S, et al. Plasma cardiac Troponin I concentrations in healthy neonates, children and adolescents measured with a high sensitive immunoassay method: high sensitive Troponin I in pediatric age. Clin Chim Acta. 2016;458:68–71. doi: 10.1016/j.cca.2016.04.029.
    1. Franzini M, Lorenzoni V, Masotti S, Prontera C, Chiappino D, Latta DD, et al. The calculation of the cardiac Troponin T 99th percentile of the reference population is affected by age, gender, and population selection: a multicenter study in Italy. Clin Chim Acta. 2015;438:376–381. doi: 10.1016/j.cca.2014.09.010.
    1. Souto ACA, de Carvalho WB. Evaluation of serum cardiac Troponin I values in children less than 1 year of age. Rev Bras Cir Cardiovasc. 2008;23:378–382. doi: 10.1590/S0102-76382008000300015.
    1. Cirer-Sastre R, Legaz-Arrese A, Corbi F, López-Laval I, George K, Reverter-Masia J. Influence of maturational status in the exercise-induced release of cardiac Troponin T in healthy young swimmers. J Sci Med Sports. 2021;24(2):116–121. doi: 10.1016/j.jsams.2020.06.019.
    1. Legaz-Arrese A, Carranza-García LE, Navarro-Orocio R, Valadez-Lira A, Mayolas-Pi C, Munguía-Izquierdo D, et al. Cardiac biomarker release after endurance exercise in male and female adults and adolescents. J Pediatr. 2017;191:96–102. doi: 10.1016/j.jpeds.2017.08.061.
    1. Pervanidou P, Akalestos A, Bastaki D, Apostolakou F, Papassotiriou I, Chrousos G. Increased circulating high-sensitivity Troponin T concentrations in children and adolescents with obesity and the metabolic syndrome: a marker for early cardiac damage? Metabolism. 2013;62:527–531. doi: 10.1016/j.metabol.2012.09.012.
    1. Vogel M, Kirsten T, Kratzsch J, Engel C, Kiess W. A combined approach to generate laboratory reference intervals using unbalanced longitudinal data. J Pediatr Endocrinol Metab. 2017;30:767–773. doi: 10.1515/jpem-2017-0171.
    1. Bajaj NS, Gutierrez OM, Arora G, Judd SE, Patel N, Bennett A, et al. Racial differences in plasma levels of N-terminal pro-B-type natriuretic peptide and outcomes: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. JAMA Cardiol. 2018;3:11–17. doi: 10.1001/jamacardio.2017.4207.
    1. Gupta DK, Daniels LB, Cheng S, deFilippi CR, Criqui MH, Maisel AS, et al. Differences in natriuretic peptide levels by race/ethnicity (from the Multi-Ethnic Study of Atherosclerosis) Am J Cardiol. 2017;120:1008–1015. doi: 10.1016/j.amjcard.2017.06.030.

Source: PubMed

3
Subscribe